Endocrinology · New York, NY
NPI
1487648176
Since 2005
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
150 E 77th St Ofc 1d
New York, NY, 10075
Phone (877) 703-3775
Groups this clinician bills Medicare through
Medicare paid, 2024
$274K
11,674 services
Medicare patients, 2024
297
Average age 74
Drug cost, 2024
$1.7M
3,156 prescriptions
Company payments, 2025
$71K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip Rabito was code 95004 (test - miscellaneous), 8,588 times for 96 patients. In total Philip Rabito billed 11,674 services in 26 codes, and Medicare paid $274K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 8,588 | 96 | $3.44 | $30K |
| 99213 Office E&M - Established | Office | 1,325 | 255 | $79.12 | $105K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 384 | 113 | $27.81 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 281 | 132 | $13.88 | $3,900 |
| 76536 Ultrasound - Nonspecific | Office | 154 | 138 | $99.04 | $15K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 123 | 121 | $163.84 | $20K |
| 93925 Duplex Scan - Extremity Arteries | Office | 120 | 118 | $218.31 | $26K |
| 93922 Duplex Scan - Extremity Arteries | Office | 103 | 84 | $71.46 | $7,361 |
| 99233 Hospital E&M - Subsequent | Facility | 102 | 13 | $102.07 | $10K |
| 95250 Test - Miscellaneous | Office | 93 | 77 | $134.70 | $13K |
| 99443 Telephone Services | Office | 79 | 62 | $109.59 | $8,658 |
| 99203 Office E&M - New | Office | 78 | 78 | $88.00 | $6,864 |
| 99214 Office E&M - Established | Office | 73 | 49 | $112.12 | $8,185 |
| 95251 Test - Miscellaneous | Office | 57 | 48 | $29.40 | $1,676 |
| 99204 Office E&M - New | Office | 24 | 24 | $140.73 | $3,377 |
By year: 2022 $271K for 3,178 services; 2023 $260K for 4,382 services; 2024 $274K for 11,674 services.
Medicare prescription drug claims, 2024
In 2024, the drug Philip Rabito prescribed most often to Medicare patients was Levothyroxine Sodium, with 421 prescriptions and refills. In total Philip Rabito wrote 3,156 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 421 | 715 | 96 | $3,666 |
| Ozempic Semaglutide | 376 | 467 | 93 | $409K |
| Mounjaro Tirzepatide | 340 | 376 | 70 | $385K |
| Jardiance Empagliflozin | 226 | 274 | 50 | $155K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 105 | 139 | 19 | $79K |
| Ezetimibe Generic | 103 | 182 | 21 | $1,907 |
| Rosuvastatin Calcium Generic | 102 | 226 | 35 | $1,772 |
| Xyosted Testosterone Enanthate | 99 | 117 | 18 | $71K |
| Synthroid Levothyroxine Sodium | 90 | 161 | 24 | $7,498 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 65 | 101 | 19 | $604 |
| Farxiga Dapagliflozin Propanediol | 55 | 69 | Under 11 | $39K |
| Atorvastatin Calcium Generic | 53 | 101 | 12 | $330 |
| Amlodipine Besylate Generic | 44 | 106 | 11 | $207 |
| Metformin Hcl Generic | 42 | 74 | 19 | $287 |
| Ramipril Generic | 42 | 84 | Under 11 | $390 |
Brand drugs: 1,761 claims; generic drugs: 1,244 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Philip Rabito $71K ($71K in general payments such as food, travel and fees) from 33 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $45K.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 55 | $45K |
| Intra-Sana Laboratories | 14 | $13K |
| Amgen Inc. AMGN | 25 | $5,878 |
| Corcept Therapeutics CORT | 11 | $2,673 |
| CeQur Corporation | 2 | $1,822 |
| Madrigal Pharmaceuticals MDGL | 9 | $463 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $400 |
| Abbvie Inc. ABBV | 13 | $269 |
| Sanofi-Aventis U.S. LLC SNY | 10 | $267 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $258 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.